Risks of the new EU Data Protection Regulation: an ESMO position paper endorsed by the European oncology community.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Data altruism and the "consent" question: a study into the "consent" models used under the GDPR and how the data altruism mechanism can act as a potential solution for the research community in the reuse of health data.Frontiers in medicine · 2024
   Review
2. Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients.ESMO open · 2017
   Article
3. Big Data in medical research and EU data protection law: challenges to the consent or anonymise approach.European journal of human genetics : EJHG · 2016
   Article
4. Samples and data accessibility in research biobanks: an explorative survey.PeerJ · 2016
   Article
5. Research participants' perceptions and views on consent for biobank research: a review of empirical data and ethical analysis.BMC medical ethics · 2015
   Review
6. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).Lancet (London, England) · 2015
   Article
7. Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2014
   Review
8. Policy: EU data protection regulation--harming cancer research.Nature reviews. Clinical oncology · 2014
   Article

Corrections and comments

• Commented on by
  Policy: EU data protection regulation--harming cancer research.2014

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as